Signaling Through Rho GTPase Pathway as Viable Drug Target

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|11|1355-1365

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.11, 2009-04, pp. : 1355-1365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Hedgehog Signaling Pathway as a Target for Anticancer Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-01 ,pp. : 147-157

Bentham Science Publishers

Access to resources Recommend Favorite

The Bcl10 / Malt1 Signaling Pathway as a Drug Target in Lymphoma

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1335-1340

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the APP Non-Amyloidogenic Signaling Pathway and Targeting -Secretase as an Alternative Drug Target for Treatment of Alzheimer's Disease

By  

Current Medicinal Chemistry, Vol. 14, Iss. 27, 2007-11 ,pp. : 2848-2864

Bentham Science Publishers

Access to resources Recommend Favorite

NO Signaling Through cGMP in Renal Tissue Fibrosis and Beyond: Key Pathway and Novel Therapeutic Target

By  

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1396-1406

Bentham Science Publishers

Access to resources Recommend Favorite

Pleiotropic Functions of Rho GTPase Signaling: A Trojan Horse or Achilles' Heel for Breast Cancer Treatment?

By  

Current Drug Targets, Vol. 11, Iss. 9, 2010-01 ,pp. : 1043-1058

Bentham Science Publishers

Access to resources Recommend Favorite